Martin Brenneman, PharmD, BCIDP
rxmartinidazole.bsky.social
Martin Brenneman, PharmD, BCIDP
@rxmartinidazole.bsky.social
ID PharmD at Baptist Health Hardin
PGY-1 & ID PGY-2 Norton Healthcare | @onupharmacy alum
#PharmRes 🦠&💊 #PharmSky #IDSky
Type-1 Diabetic 💉 | He/Him | Views are my own
Reposted by Martin Brenneman, PharmD, BCIDP
It’s official. 3 days is the new 5! New #ATS guidelines
May 20, 2025 at 11:56 PM
Reposted by Martin Brenneman, PharmD, BCIDP
To kick off a new series ID/AMS Reading Lists series, SIDP is here to help you "Hit 'Em with Your Best Nudge"! Check out this noticeable (and unnoticed) nudge comments in AMS! #IDSky #rxsky #pharmsky #AMSsky #medsky #SIDP #EvidenceBasedMedicine #IDPharmacy #Microbiology #Nudge #NudgeComments
May 20, 2025 at 12:10 PM
Reposted by Martin Brenneman, PharmD, BCIDP
It has been a while since our last #ICYMI post, so to get back into it we're sharing TWO tables worth of recent articles that YOU should really check out! From PK/PD to antimicrobial resistance to diagnostic stewardship, there's something for everyone! #IDSky #rxsky #pharmsky #AMSsky #medsky #SIDP
May 5, 2025 at 3:53 PM
Reposted by Martin Brenneman, PharmD, BCIDP
🙍‍♀️ w/Staph aureus BSI have high rates of mortality & metastatic infx (Think ❤️,🫁,🦴, & 🔩!). Huge shout out to these authors for succinctly summarizing A LOT of complex data! Truly a huge 🏋️‍♂️

👀 Figure 2 & Table 2

doi.org/10.1001/jama.2025.4288

#IDSky #rxsky #pharmsky #AMSsky #medsky #SIDP
April 26, 2025 at 7:39 PM
Reposted by Martin Brenneman, PharmD, BCIDP
Be sure to check out and save the recent review article on Malaria in @NEJM.org for an overview of diagnosis, treatment, and prevention strategies including roll out of recently approved malaria vaccines! www.doi.org/10.1056/NEJMra2405313 #IDSky #rxsky #pharmsky #AMSsky #medsky #SIDP
www.doi.org
April 23, 2025 at 12:40 PM
Reposted by Martin Brenneman, PharmD, BCIDP
Finally! Some helpful material to educate the public on the penicillin allergy myth, from one of my fav podcasts 🎙️, #Freakonomics 👇🏻 #IDsky #Pharmsky #AMSsky

🔗: podcasts.apple.com/us/podcast/f...
617. Are You Really Allergic to Penicillin?
Podcast Episode · Freakonomics Radio · 01/10/2025 · 1h 4m
podcasts.apple.com
January 10, 2025 at 12:11 PM
Reposted by Martin Brenneman, PharmD, BCIDP
Administered three times daily, up to 1.5 g cephalexin was well tolerated and effective in children with bone and joint infections.

#IDSky
#PedSky

academic.oup.com/jac/advance-...
Efficacy and tolerability of high-dose cefalexin 45 mg/kg/dose (maximum 1.5 g) three times daily in children with bone and joint infections
AbstractBackground. Cefalexin, a first-generation cephalosporin, is commonly used as oral continuation therapy for paediatric bone and joint infections (BJ
academic.oup.com
January 2, 2025 at 2:32 AM